WO2001084146B1 - Biocapteur multiplex sensible a spectrometrie de masse base sur l'immuno-pcr - Google Patents

Biocapteur multiplex sensible a spectrometrie de masse base sur l'immuno-pcr

Info

Publication number
WO2001084146B1
WO2001084146B1 PCT/IB2001/000957 IB0100957W WO0184146B1 WO 2001084146 B1 WO2001084146 B1 WO 2001084146B1 IB 0100957 W IB0100957 W IB 0100957W WO 0184146 B1 WO0184146 B1 WO 0184146B1
Authority
WO
WIPO (PCT)
Prior art keywords
antibody
spectrometry
immuno
pcr
sensitive
Prior art date
Application number
PCT/IB2001/000957
Other languages
English (en)
Other versions
WO2001084146A3 (fr
WO2001084146A2 (fr
Inventor
Curt T Reimann
Original Assignee
Forskarpatent I Syd Ab
Curt T Reimann
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Forskarpatent I Syd Ab, Curt T Reimann filed Critical Forskarpatent I Syd Ab
Priority to AU2001258700A priority Critical patent/AU2001258700A1/en
Publication of WO2001084146A2 publication Critical patent/WO2001084146A2/fr
Publication of WO2001084146A3 publication Critical patent/WO2001084146A3/fr
Publication of WO2001084146B1 publication Critical patent/WO2001084146B1/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6804Nucleic acid analysis using immunogens
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • C12Q1/6816Hybridisation assays characterised by the detection means
    • C12Q1/682Signal amplification
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306Solid-phase reaction mechanisms
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2458/00Labels used in chemical analysis of biological material
    • G01N2458/10Oligonucleotides as tagging agents for labelling antibodies
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2458/00Labels used in chemical analysis of biological material
    • G01N2458/15Non-radioactive isotope labels, e.g. for detection by mass spectrometry

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)

Abstract

La présente invention concerne un procédé de détection de substances, selon lequel on procède à la détection immunologique d'une substance, on amplifie ensuite un acide nucléique marqueur lié à un anticorps, et on identifie le marqueur amplifié. Le procédé de détection de l'invention fait appel à la spectrométrie de masse qui, en décelant la présence et en identifiant la masse de l'acide nucléique marqueur, permet de détecter la liaison spécifique de l'anticorps avec un antigène.
PCT/IB2001/000957 2000-05-04 2001-05-04 Biocapteur multiplex sensible a spectrometrie de masse base sur l'immuno-pcr WO2001084146A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2001258700A AU2001258700A1 (en) 2000-05-04 2001-05-04 A sensitive, multiplexed mass-spectrometry-based biosensor based on immuno-pcr

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0001670A SE0001670D0 (sv) 2000-05-04 2000-05-04 Mass-spectrometry-based biosensor
SE0001670-9 2000-05-04

Publications (3)

Publication Number Publication Date
WO2001084146A2 WO2001084146A2 (fr) 2001-11-08
WO2001084146A3 WO2001084146A3 (fr) 2002-04-11
WO2001084146B1 true WO2001084146B1 (fr) 2002-07-04

Family

ID=20279569

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2001/000957 WO2001084146A2 (fr) 2000-05-04 2001-05-04 Biocapteur multiplex sensible a spectrometrie de masse base sur l'immuno-pcr

Country Status (3)

Country Link
AU (1) AU2001258700A1 (fr)
SE (1) SE0001670D0 (fr)
WO (1) WO2001084146A2 (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003530130A (ja) 2000-04-14 2003-10-14 メタボロン インコーポレイテッド メタボロミクスを使用した薬物発見、疾患の処置、及び診断のための方法
US7329489B2 (en) 2000-04-14 2008-02-12 Matabolon, Inc. Methods for drug discovery, disease treatment, and diagnosis using metabolomics
DE10200374A1 (de) * 2002-01-08 2003-07-24 Friz Biochem Gmbh Verfahren zur qualitativ und quantitativ vergleichenden Detektion chemischer Substanzen
TWI375796B (en) 2003-04-18 2012-11-01 Becton Dickinson Co Immuno-amplification
US8304192B2 (en) 2004-03-05 2012-11-06 University Of Toledo Methods and compositions for assessing nucleic acids and alleles
US7476502B2 (en) 2004-04-12 2009-01-13 Willey James C Methods and compositions for assaying analytes
WO2006128010A2 (fr) * 2005-05-26 2006-11-30 The Trustees Of Boston University Quantification d'acides nucleiques et de proteines au moyen d'etiquettes de masse d'oligonucleotides
US8849577B2 (en) 2006-09-15 2014-09-30 Metabolon, Inc. Methods of identifying biochemical pathways
JP2009219388A (ja) * 2008-03-14 2009-10-01 Jsr Corp イムノpcr用磁性粒子、標的物質の検出方法、および標的物質の検出キット
AU2014248759B2 (en) * 2013-03-13 2020-02-27 Meso Scale Technologies, Llc. Improved assay methods
US10114015B2 (en) 2013-03-13 2018-10-30 Meso Scale Technologies, Llc. Assay methods
AU2015259048B2 (en) 2014-05-15 2021-09-09 Meso Scale Technologies, Llc. Improved assay methods
AU2017370751B2 (en) 2016-12-09 2023-11-09 Ultivue, Inc. Improved methods for multiplex imaging using labeled nucleic acid imaging agents
US10246738B2 (en) 2017-03-31 2019-04-02 Ultivue, Inc. DNA-antigen exchange and amplification
US20210214776A1 (en) * 2018-09-26 2021-07-15 The University Of North Carolina At Chapel Hill Compounds, compositions, and methods for improving assays

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996029432A1 (fr) * 1995-03-22 1996-09-26 Trustees Of Boston University Procedes de detection de paracoccidioides
DE19802576B4 (de) * 1998-01-23 2004-10-28 Xerion Pharmaceuticals Ag Verfahren zur gleichzeitigen Identifizierung von Proteinen und ihren Bindungspartnern
AU772069B2 (en) * 1999-03-23 2004-04-08 Merck Patent Gesellschaft Mit Beschrankter Haftung Protein isolation and analysis

Also Published As

Publication number Publication date
SE0001670D0 (sv) 2000-05-04
AU2001258700A1 (en) 2001-11-12
WO2001084146A3 (fr) 2002-04-11
WO2001084146A2 (fr) 2001-11-08

Similar Documents

Publication Publication Date Title
WO2001084146B1 (fr) Biocapteur multiplex sensible a spectrometrie de masse base sur l'immuno-pcr
EP0951297B1 (fr) Detection d'antigenes par le biais de conjugues anticorps - oligonucleotides
EP1288313A3 (fr) Système et méthode pour analyser des molécules d'acide nucléique
EP1156329A3 (fr) Essais à modification moléculaire
WO2001049823A3 (fr) Dosage pour la detection de bacillus anthracis
WO2001057522A3 (fr) Methodes immunochromatographiques destinees a detecter une substance dans un echantillon par l'emploi de nanocristaux semi-conducteurs comme agents de marquage detectables
CA2285919A1 (fr) Tests et trousses de diagnostic pour clostridium difficile
GB2431988A (en) Assay device & method
WO2003078449A3 (fr) Dosage rapide et sensible base sur la proximite permettant de detecter et de quantifier des proteines de liaison
WO2003040670A3 (fr) Procede d'identification de capteurs de transfert d'energie pour analytes
EP0837141A3 (fr) Procédé pour détecter un acide nucléique ciblé, procédé pour sa détermination quantitative et composés pyryliums pour l'analyse en chimioluminescence
CA2130072A1 (fr) Methode de detection d'un agent pathogene au moyen d'un virus
WO2003095968A3 (fr) Procede de detection simultanee d'un antigene et d'un anticorps d'un microorganisme infectueux
WO1998014611A3 (fr) Detection et identification d'enterovirus non poliovirus
WO2003054225A3 (fr) Procede de determination d'analytes du type acide nucleique
EP0346119A3 (fr) Essai anti-FC pour détecter des anticorps
US6399299B1 (en) Amplified array analysis system
ATE513058T1 (de) Verdrängungsassay zur detektion von nukleinsäureoligomer-hybridisierungsereignissen
WO2006113522A3 (fr) Methodes de detection du virus de l'hepatite c
CA2539452A1 (fr) Compositions et procedes pour l'analyse d'analytes cibles
FR2728687B1 (fr)
HUP9801448A2 (hu) Eljárás antitesttermelés kimutatására
WO2004023146A3 (fr) Procedes et reactifs pour doser des interactions moleculaires
WO2003057709A3 (fr) Methode et reactif de detection de proteines et de peptides
WO2001027621A3 (fr) DOSAGE IMMUNOENZYMATIQUE D'INHIBITION (iELISA) PERMETTANT DE DETECTER ET QUANTIFIER LES ANTICORPS PRESENTS DANS DES PRELEVEMENTS BIOLOGIQUES

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

AK Designated states

Kind code of ref document: B1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: B1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase in:

Ref country code: JP